Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on providing hearing loss sufferers with innovative solutions today announces additional patents for its growing ...

Shareholder distributions are appropriate. Capital intensity of the industry remains low and gross margins high. In addition, Cochlear enjoys high cash conversion, enabling it to typically pay out 70% ...

A new study from Oregon Health & Science University is the first to suggest that binaural pitch fusion—a process that ...

Jefferies analyst David Stanton upgraded Cochlear Ltd. shares from Hold to Buy, adjusting the price target slightly upward from AUD305.00 to AUD308.00. The upgrade comes as the $10.91 billion market ...

Inc. (NASDAQ: COCH), a small-cap medical device company with a market capitalization of $29.4 million specializing in hearing loss solutions, has announced the expansion of its patent portfolio with ...

Highmark Health today announced that Mark Sevco, chief operating officer of Sutter Health in Northern California, has been ...

GovCIO Media & Research, a leading federal technology media company, announced the finalists for the annual CyberScape ...

Age-Related Hearing Loss (ARHL) is a prevalent condition affecting a significant portion of the elderly population worldwide. It is characterized by a ...